Regeneron Pharmaceuticals Inc. (REGN)

Index:

Nasdaq 100

$ 578.05
   
  • Change Today:
    $8.88
  • 52 Week High: $998.23
  • 52 Week Low: $490.81
  • Currency: US Dollars
  • Shares Issued: 107.80m
  • Volume: 745,708
  • Market Cap: $62,314m
  • RiskGrade: 129

Regeneron Pharmaceuticals Covid-19 antibodies 100% effective in blocking infections

By Alexander Bueso

Date: Tuesday 26 Jan 2021

LONDON (ShareCast) - (Sharecast News) - Regeneron Pharmaceuticals antibody cocktail severely curtails Covid-19 symptoms and infections, the results of a late-stage trial showed.

The trial involving 400 patients with at least one household member sick from Covid-19 showed that the two-antibody cocktail, known as REGEN-COV, completely cut symptomatic infections of the novel coronavirus.

Overall rates of infections meanwhile were reduced by approximately half.

A rival treatment from Eli Lilly, bamlanivimab, had shown a similar efficacy the week before, reducing Covid-19 infections among nursing home resident in a trial by 80%.

As of 1650 GMT, Regeneron shares had slipped 1.11% to $542.14.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

REGN Market Data

Currency US Dollars
Share Price $ 578.05
Change Today $ 8.88
% Change 1.56 %
52 Week High $998.23
52 Week Low $490.81
Volume 745,708
Shares Issued 107.80m
Market Cap $62,314m
RiskGrade 129

What The Brokers Say

Strong Buy 9
Buy 11
Neutral 4
Sell 2
Strong Sell 0
Total 26
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 17-Oct-2025

Time Volume / Share Price
16:00 107,698 @ $578.05
15:59 100 @ $578.25
15:59 146 @ $578.29
15:59 200 @ $578.09
15:59 100 @ $577.93

Top of Page